Slayback Pharma Limited Liability Company

ELIZZA

chemical contraceptives;

MERZEE

chemical contraceptives;

PREVDUO

Medicines and pharmaceutical preparations for human use, namely, anticholinergics, antimuscarinics, cholinesterase inhibitors, combination of antimuscarinic agent and cholinesterase inhibitor, muscle relaxants, muscle relaxant antagonists, anesthetic preparations, neuromuscular blocking agents, combination products to reverse neuromuscular blockade; Medicines and pharmaceutical preparations for the reversal of the effects of non-depolarizing neuromuscular blocking agents, while minimizing the peripheral muscarinic effects;

SLAYBACK

pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as X-ray contrast reagents;

SLAYBACK CONNECT

Educational services, namely, conducting classes and seminars in the field of oncological disease;The mark consists of word Slayback in black, above CONNECT in red (Pantone 202) with a gray (Pantone Cool Gray 3 C) molecule figure representing the O, centered in a partial, rectangular shaped box in gray (Pantone Cool Gray 3 C).;SLAY BACK CONNECT;The color(s) gray (or Pantone Cool Gray 3 C), red (or Pantone 202) and black is/are claimed as a feature of the mark.;Providing medical information relating to oncological diseases and pharmaceuticals used to treat oncological diseases, as well as medical information to help support ongoing compliance and adherence to oncological disease therapies, and to enhance patients' knowledge of oncological diseases;

SLAYBACK PHARMA

pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as X-ray contrast reagents;PHARMA;

VIVIMUSTA

Pharmaceutical products for the treatment of cancer;

XTESO

The mark consists of pieces of circles in blue rotating around each other and sort of forming a target to the left of XTESO.;Hormonal preparation for medicinal use; Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations for the treatment of hypogonadism;Printed educational materials on the subject of testosterone deficiency;The color(s) blue is/are claimed as a feature of the mark.;Providing online information on the subject of testosterone deficiency;